PsychoGenics’ High Data Security Standards Are Certified by The NIH
PsychoGenics Inc. (PGI), a provider of AI-based phenotypic platforms and preclinical assays for the development of therapeutics for pain, neurodegenerative,...
Privacy Policy
This Policy explains how PsychoGenics, Inc. (also referred to as “PGI”, “we” or “our”) collects, holds, uses and discloses information...
Sunovion and PsychoGenics Announce that SEP-363856 Has Received FDA Breakthrough Therapy Designation for the Treatment of People with Schizophrenia
May 10, 2019 – Marlborough, Mass., and Paramus, N.J., – Sunovion Pharmaceuticals Inc. (Sunovion) and PsychoGenics Inc. (PsychoGenics), today announced...
We Need a New Prozac: The Demand for Brain Drug Innovation
[et_pb_section fb_built=”1″ _builder_version=”4.17.6″ _module_preset=”default” global_colors_info=”{}”][et_pb_row _builder_version=”4.17.6″ _module_preset=”default” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.17.6″ _module_preset=”default” global_colors_info=”{}”][et_pb_post_title meta=”off” featured_image=”off” _builder_version=”4.17.6″ _module_preset=”default” global_colors_info=”{}”][/et_pb_post_title][et_pb_text _builder_version=”4.17.6″ _module_preset=”default” global_colors_info=”{}”]...
Sunovion and PsychoGenics Initiate DIAMOND Phase 3 Clinical Studies for SEP-363856 in the Treatment of Adults and Adolescents with Schizophrenia
September 27, 2019 – Marlborough, Mass., and Paramus, N.J. , – Sunovion Pharmaceuticals Inc. (Sunovion) and PsychoGenics Inc. (PsychoGenics), today...
Precision-Driven Preclinical Microdialysis Services
PsychoGenics’ preclinical microdialysis services offer capabilities in single or dual probe microdialysis studies. With our in-house bioanalytical experts, you benefit...
Immunohistochemistry (IHC) & Histology Services
PsychoGenics’ immunohistochemistry (IHC) and histology services offer exceptional data quality, enabling the exploration of standard and novel biomarkers. Our high-throughput...
Preclinical CNS Services
At PsychoGenics, our pioneering strategies and advanced preclinical testing services deliver the high-quality data you need to make critical go/no-go...
Preclinical Ex Vivo Sample Biomarker Analysis Services
PsychoGenics offers extensive in-house ex vivo sample biomarker analysis services, equipped with seasoned expertise, advanced facilities, and state-of-the-art equipment. Our...
PsychoGenics Chief Innovation Officer Honored for Scientific Excellence
PsychoGenics announces that Daniela Brunner Ph.D., Chief Innovation Officer, was named the recipient of Great Minds in STEMTM (GMiS) Scientist of...